The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.
about
Risks of serious infections in children treated with biologic response-modifying drugs: Bacterial infection risk in children with juvenile idiopathic arthritis.Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy
P2860
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The risk of hospitalized infec ...... juvenile idiopathic arthritis.
@en
The risk of hospitalized infec ...... juvenile idiopathic arthritis.
@nl
type
label
The risk of hospitalized infec ...... juvenile idiopathic arthritis.
@en
The risk of hospitalized infec ...... juvenile idiopathic arthritis.
@nl
prefLabel
The risk of hospitalized infec ...... juvenile idiopathic arthritis.
@en
The risk of hospitalized infec ...... juvenile idiopathic arthritis.
@nl
P2093
P2860
P1476
The risk of hospitalized infec ...... juvenile idiopathic arthritis
@en
P2093
Fenglong Xie
Jeffrey R Curtis
John W Baddley
Kenneth G Saag
Melissa L Mannion
P2860
P2888
P356
10.1186/S13075-016-1109-8
P577
2016-09-22T00:00:00Z
P6179
1027957806